Using the 5-HT transporter dependency of p-chloroamphetamine-stimulated 5-HT release to determine the nature of fenfluramine-induced 5-HT transporter loss.
Westphalen
R I
RI
Clinical Research Centre, Royal Brisbane Hospital Research Foundation, Bancroft Centre, Hersion, Australia.
Dodd
P R
PR
D000818:Animals; D001921:Brain / Q000187:drug effects / Q000378:metabolism; D002352:Carrier Proteins / Q000187:drug effects*; D005277:Fenfluramine / Q000494:pharmacology*; D008297:Male; D008562:Membrane Glycoproteins / Q000187:drug effects*; D026901:Membrane Transport Proteins; D009419:Nerve Tissue Proteins; D051381:Rats; D017207:Rats, Sprague-Dawley; D017208:Rats, Wistar; D012701:Serotonin / Q000378:metabolism*; D050486:Serotonin Plasma Membrane Transport Proteins; D013574:Synaptosomes / Q000187:drug effects / Q000378:metabolism; D014316:Tritium; D010133:p-Chloroamphetamine / Q000494:pharmacology*
D002352:Carrier Proteins; D008562:Membrane Glycoproteins; D026901:Membrane Transport Proteins; D009419:Nerve Tissue Proteins; D050486:Serotonin Plasma Membrane Transport Proteins; C493232:Slc6a4 protein, rat; D014316:Tritium; D005277:Fenfluramine; D012701:Serotonin; D010133:p-Chloroamphetamine